Document Detail


 Gut microbiota and nonalcoholic fatty liver disease.
MedLine Citation:
PMID:  22700625     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
 Recent evidence has linked obesity and the metabolic syndrome with gut dysbiota. The precise mechanisms underlying that association are not entirely understood; however, microbiota can enhance the extraction of energy from diet and regulate whole-body metabolism towards increased fatty acids uptake from adipose tissue and shift lipids metabolism from oxidation to de novo production. Obesity and high fat diet relate to a specific gut microbiota, which is enriched in Firmicutes and with less Bacterioidetes. Microbiota can also play a role in the development of hepatic steatosis, necroinflammation and fibrosis. In fact, some studies have shown an association between small intestinal bacterial overgrowth, increased intestinal permeability and nonalcoholic steatohepatitis (NASH). That association is, in part, due to increased endotoxinaemia and activation of the Toll-like receptor-4 signaling cascade. Preliminary data on probiotics suggest a potential role in NASH treatment, however randomized controlled clinical trials are still lacking.
Authors:
Mariana V Machado; Helena Cortez-Pinto
Related Documents :
8878245 - Reverse cholesterol transport in the rat following a short-term intravenous infusion of...
8027755 - Early diagnosis of fat embolism syndrome by automated image analysis of alveolar macrop...
21429045 - A krill oil supplemented diet reduces the activities of the mitochondrial tricarboxylat...
24901355 - Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans.
7487575 - Effect of marginal ascorbic acid deficiency on saliva level of cortisol in the guinea pig.
223375 - Comparison of the mechanism of action of vitamin d3 and 1 alpha-oh d3 under conditions ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annals of hepatology     Volume:  11     ISSN:  1665-2681     ISO Abbreviation:  Ann Hepatol     Publication Date:    2012 Jul-Aug
Date Detail:
Created Date:  2012-06-15     Completed Date:  2012-10-22     Revised Date:  2013-05-16    
Medline Journal Info:
Nlm Unique ID:  101155885     Medline TA:  Ann Hepatol     Country:  Mexico    
Other Details:
Languages:  eng     Pagination:  440-9     Citation Subset:  IM    
Affiliation:
Departamento de Gastrenterologia, Hospital Santa Maria, CHLN, Lisbon, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bacteria / growth & development*,  metabolism
Dietary Carbohydrates / metabolism
Energy Metabolism
Fatty Liver / metabolism,  microbiology*,  therapy
Fructose / metabolism
Humans
Intestines / microbiology*
Obesity / metabolism,  microbiology
Prebiotics
Probiotics / therapeutic use
Risk Factors
Chemical
Reg. No./Substance:
0/Dietary Carbohydrates; 0/Prebiotics; 30237-26-4/Fructose
Comments/Corrections
Comment In:
Ann Hepatol. 2013 Jan-Feb;12(1):161-3   [PMID:  23293210 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:   Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice.
Next Document:   Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patie...